New Clinical Data Released at the World Congress of Neuroendoscopy Conclusively Points to Vycor's VBAS Reducing Post Operative Patient Length of Stay in Hospital

BOCA RATON, Florida, November 18, 2015

Vycor Medical, Inc. (OTCQB: VYCO) reports that a "Poster" presented at the VII World Congress of Neuroendoscopy recently held in Puerto Vallarta on a 64 Patient retrospective study showed statistically meaningful reductions in patient post operative hospital stay, while still providing effective access.

The paper looked at Intracerebral Hemorrhage Evacuation that accounts for 10-15% of cerebrovascular disease and compared three different treatment approaches: medical management and observation; drainage through a VBAS with endoscopic assistance; and finally drainage through a conventional craniotomy. The analysis was performed by neurosurgeons at the Department of Neurological Surgery, National Institute of Neurology and Neurosurgery "Manuel Velasco Suarez" Mexico City, Mexico and was presented earlier this month.

The study states that there is no agreement on the selection of type of treatment for Intracerebral Hemorrhage. In the retrospective analysis, 64 patients who had undergone one of the three approaches were analyzed.  Complete drainage of the of the hematoma was achieved in 83.3% of the cases using the VBAS but even more significant was the average hospital stay of 8.08 days with a statistically significant difference against the other two groups. Furthermore, mortality at 6 months had a significant difference between the medical treatment group and the VBAS and Endoscope group, 42.9% vs 0% for the VBAS and Endoscope group.

"We have for some time had direct feedback from physicians that they believed using VBAS reduced the Operating Room time in any given procedure which is a large component of overall cost', said Peter Zachariou, CEO of Vycor. "The other main cost born by the hospital is the time the patient has to stay in its care. This clinical data further supports our belief that not only does VBAS improve patient outcome it furthermore saves hospitals money. This high-quality clinical data can help support the greater usage of VBAS and its adoption as the standard of care for brain retraction and access."

The article follows on from six other published studies this year, including one featured on the cover of the Journal of Neurosurgery. It is also the fifth clinical paper or abstract for VBAS published internationally highlighting its growing adoption.

About ViewSite™ Surgical Access System